- Home
- ALVO vs FORM Comparison
ALVO vs FORM Comparison
Compare ALVO & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- FORM
- Stock Information
- Founded
- ALVO 2013
- FORM 1993
- Country
- ALVO Luxembourg
- FORM United States
- Employees
- ALVO N/A
- FORM N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- FORM Semiconductors
- Sector
- ALVO Health Care
- FORM Technology
- Exchange
- ALVO Nasdaq
- FORM Nasdaq
- Market Cap
- ALVO 2.5B
- FORM 2.7B
- IPO Year
- ALVO N/A
- FORM N/A
- Fundamental
- Price
- ALVO $9.61
- FORM $34.09
- Analyst Decision
- ALVO Buy
- FORM Buy
- Analyst Count
- ALVO 1
- FORM 7
- Target Price
- ALVO $18.00
- FORM $41.17
- AVG Volume (30 Days)
- ALVO 314.4K
- FORM 539.6K
- Earning Date
- ALVO 08-14-2025
- FORM 07-30-2025
- Dividend Yield
- ALVO N/A
- FORM N/A
- EPS Growth
- ALVO N/A
- FORM N/A
- EPS
- ALVO 0.34
- FORM 0.69
- Revenue
- ALVO $587,890,000.00
- FORM $766,230,000.00
- Revenue This Year
- ALVO $36.18
- FORM $2.18
- Revenue Next Year
- ALVO $42.61
- FORM $7.14
- P/E Ratio
- ALVO $28.20
- FORM $49.22
- Revenue Growth
- ALVO 413.92
- FORM 15.33
- 52 Week Low
- ALVO $7.35
- FORM $22.58
- 52 Week High
- ALVO $13.70
- FORM $56.87
- Technical
- Relative Strength Index (RSI)
- ALVO 59.59
- FORM 46.56
- Support Level
- ALVO $8.51
- FORM $33.60
- Resistance Level
- ALVO $8.91
- FORM $36.40
- Average True Range (ATR)
- ALVO 0.36
- FORM 1.12
- MACD
- ALVO 0.13
- FORM -0.29
- Stochastic Oscillator
- ALVO 99.22
- FORM 21.21
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.